How do you steer your patients through the threat of EBV+ PTLD?
Epstein-Barr virus–positive post-transplant lymphoproliferative disease (EBV+ PTLD) is a life-threatening malignancy that presents challenges in the management of transplant patients.
Share your experience and see how other clinicians have responded
We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse this site, you will accept our use of cookies. For more information, please read our Privacy Policy.
You are now leaving EBVPTLD.com
Please be aware that the sponsors of this site are not responsible for and do not manage the accuracy, content, practices, or standards on the site you are about to enter.
Contact Atara
For direct or time-sensitive inquiries about EBV+ PTLD, please contact Atara at: